All News #Library
Biotech
Glycomine secures $115M for GLM101 Phase 2b trial in PMM2-CDG
16 Apr 2025 //
BUSINESSWIRE
Glycomine Appoints Joshua Grass as Chairperson of Board of Directors
10 Oct 2024 //
BUSINESSWIRE
Glycomine Gets FDA Fast Track For GLM101 In PMM2-CDG
18 Sep 2024 //
BUSINESSWIRE
Glycomine Announces First Pediatric Patient Dosed in Phase 2 Study of GLM101
11 Dec 2023 //
BUSINESSWIRE
Glycomine Presents at ASHG 2023 Data from Ongoing Natural History Study
02 Nov 2023 //
BUSINESSWIRE
Glycomine Announces First Patient Dosed in Phase 2 Study of GLM101
09 Jan 2023 //
BUSINESSWIRE

Market Place
Sourcing Support